Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer

Clinical trial NCT01644968 · COMPLETED

Trial details

NCT number: NCT01644968
Sponsor: Providence Health & Services
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2003-11-01
Primary completion: 2009-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.